(Q35757641)

English

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

scientific article published on 10 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

secondary progressive multiple sclerosis

0 references

multiple sclerosis

0 references

mesenchymal stem cell

1 reference

based on heuristic

inferred from title

object named as

Peter Connick

1

0 references

object named as

Rickie Patani

5

0 references

Alan J. Thompson

object named as

Alan J Thompson

10

0 references

Alastair Compston

11

object named as

Alastair Compston

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

David H. Miller

13

object named as

David H Miller

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

9

object named as

Daniel R Altmann

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Madhan Kolappan

2

object named as

Madhan Kolappan

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Siddharthan Chandran

14

object named as

Siddharthan Chandran

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

author name string

Charles Crawley

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Daniel J Webber

4

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Andrew W Michell

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Ming-Qing Du

7

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Shi-Lu Luan

8

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Michael A Scott

12

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

publication date

10 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Lancet Neurology

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

150-156

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

The prospect of stem cells as multi-faceted purveyors of immune modulation, repair and regeneration in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Proof of concept studies for tissue-protective agents in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Remyelination in the CNS: from biology to therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Linear mixed effects models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

The epidemiology of multiple sclerosis in Europe.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Application of array CGH on archival formalin-fixed paraffin-embedded tissues including small numbers of microdissected cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

2 October 2017

Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

25 September 2018

Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

25 September 2018

Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

25 September 2018

Human mesenchymal stem cells signals regulate neural stem cell fate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

25 September 2018

Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

25 September 2018

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

25 September 2018

Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279697

25 September 2018

Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22236384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The curious incident of disability in multiple sclerosis trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/22236384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S1474-4422(11)70305-2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35757641&oldid=1743020327"